p53 as a target for anti-cancer drug development. (Q36475676)

scientific article

Language	Label	Description	Also known as
English	p53 as a target for anti-cancer drug development.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

16690321

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690321%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

p53 as a target for anti-cancer drug development (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

16690321

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690321%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

author

Claude Caron De Fromentel

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

16690321

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690321%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

Alain Puisieux

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

16690321

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690321%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

author name string

Benjamin Pierre Bouchet

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

16690321

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690321%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

Carlos María Galmarini

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed ID

16690321

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690321%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

publication date

9 May 2006

1 reference

stated in

Europe PubMed Central

PubMed ID

16690321

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690321%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

published in

Critical Reviews in Oncology Hematology

1 reference

stated in

Europe PubMed Central

PubMed ID

16690321

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690321%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

volume

58

1 reference

stated in

Europe PubMed Central

PubMed ID

16690321

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690321%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

issue

3

1 reference

stated in

Europe PubMed Central

PubMed ID

16690321

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690321%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

page(s)

190-207

1 reference

stated in

Europe PubMed Central

PubMed ID

16690321

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690321%20AND%20SRC:MED&resulttype=core&format=json

p53 as a target for anti-cancer drug development. (Q36475676)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

p53 as a target for anti-cancer drug development. (Q36475676)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search